Favorite Newsletters?

I am looking to see what newsletters are people's favorites/go to as I want to sign up for various finance-related and market update newsletters. Are there any in particular I should sign up for, either free or paid for? I hear Guggenheim has an appealing newsletter

32 Comments
 

The FT has killer newsletters, but many require some sort of account or subscription. If you're considering a newspaper subscription anyway, their DD newsletter about all things M&A is really strong.

Other than that, being more on the entrepreneurial side I would recommend Ben Evan's newsletter, Founder Weekly and a couple VC specific ones like Von Perger or John Gannon.

 

Had a digital preview subscription for free and really suffered once I lost it. Didn't take long until I was back on it...

Zerohedge is a mixed bag, in my opinion. Used to visit it every now and then but eventually lost interest.

 
  • Morning Brew is alright & very popular so a good one to read
  • Bloomberg 5 Things to Start Your Day is great
  • Yahoo Finance Morning Brief is interesting most days
  • Techmeme is good if your work is connected w/ Tech at all
  • Investopedia Market Sum is one of my favorites bc they send it after trading is over for the day
  • FT & WSJ both have good ones if you have a subscription
  • Lastly, check out Vitaluy Katsenelson's newsletter if u want something different
Array
 

Big fan of Axios' news letters - especially the general one and Axios Markets. They also have a really good one - Axios Pro Rata - about all thingss PE/ VC/ M&A

 

Matt Levine's Money Stuff is the best FT Alphaville is solid Today in Tech by AngelList is good for VC/tech Morning Brew is just ok, the content is pretty basic The Water Coolest is meh Finimize sucks

all free

 
Most Helpful
"rollcall" Matt Levine's Money Stuff is the best FT Alphaville is solid Today in Tech by AngelList is good for VC/tech Morning Brew is just ok, the content is pretty basic The Water Coolest is meh Finimize sucks

all free

I'm going to be a second vote for Money Stuff. I'm not sure that I've ever received any sort of economic value from reading it, but holy s*** is it a good read. It also gives you a bunch of cool edge-case scenario stories for boring work cocktail hours.

The only difference between Asset Management and Investment Research is assets. I generally see somebody I know on TV on Bloomberg/CNBC etc. once or twice a week. This sounds cool, until I remind myself that I see somebody I know on ESPN five days a week.
 
"Five Star Man" Is the daily dirtnap worth it?

I'll respond but might be best to check in with me in a few months since I just signed up for it recently.

I've always enjoyed Dillian's writing but never wanted to pull the trigger to pay for it (lol!). All the market voloatility a couple months ago and me making an effort to pay more attention to the market vs. blindly contributing to retirement made me pull the trigger.

I've liked it so far, he is great at market sentiment. It is not a "trading" newsletter (his words) but I've used things he's dropped in the newletter to make some good money in the last few weeks/months in the market.

 

Stratechery is THE best newsletter for Tech. It takes hard strategy concepts like two-sided markets and price war dynamics and shows how they apply to the actions of current players like Apple and Amazon. The concepts are intermediate to advanced MBA level, but he makes it very approachable.

Array
 

+1 Petition, esp for any college kids who want to learn about multiples and metrics that actual investors look at for certain companies. Issue on Hertz yesterday was quick yet detailed summary.

 

The Pharma Guy and @Anon1254" would love to hear what you guys use for Healthcare.

I get the Paul Keckley weekly email, recently signed up for Healthcare Dive and MedTech Dive.

Do any of the scientific journals send something out for clinical trials and/or new breakthroughs?

Go all the way
 

My go to ones are:

  • Fierce Pharma/Biotech

  • Businesswire (healthcare sub-portal)

  • Bionews Feed (a lot of clinical trial related things)

  • News Medical/Life Sciences

  • HCP Live (rare diseases sub-portal)

  • City AM (pharmaceuticals sub-portal)

  • BioSpace

  • PR Newswire (healthcare sub-portal)

  • Life-Sciences-USA.com (also have European and Asian version of the website)

 

Axios edge, Axios markets and Axios pro rata. Also atom finance' s morning and afternoon briefings are nice and they have a short M&A section that hits the spot.

All free of course.

 

i don't read news all the time and often i just get the info from the title.

Only Matt Levine has kept my interest. I do not bother reading any other regular newsletter. Everything else I search for is targeted. I feel bad for not reading every single newsletter of his though.

made new unrelated account - dont reply or message as i never use it. 
 

Dignissimos dolores ea atque expedita voluptatibus incidunt. Quis architecto laboriosam quas et. Dolore voluptatem itaque a est officiis ex nihil. Possimus dolorem a ipsum. Nihil eaque fugiat harum animi velit. Enim illum quia ut dignissimos tempore perferendis sit. Qui minus velit sunt quis soluta.

Veniam totam dolore tempore tenetur. Libero voluptatem officia quaerat consequuntur dolorem aliquid repellat. Possimus eum incidunt consequuntur quod. Voluptatem molestiae dolorem placeat cumque quia facilis. Magnam suscipit qui voluptatibus quidem quia possimus. Unde qui et dolorem cumque voluptatem.

Similique in quia natus sint laborum quod nesciunt. Non reprehenderit consectetur maxime nam. Atque similique harum aut sed nihil temporibus saepe voluptate. Vel vero molestias repellendus mollitia rem. Accusantium qui voluptatum quaerat debitis dolores itaque. Fugit officia maiores velit provident hic quidem ipsam.

Dignissimos soluta explicabo ipsam distinctio esse. Sed aut consequatur repudiandae ipsam amet beatae. Dolores magnam autem quas dolorem ullam architecto non.

 

Sint neque vitae magnam nesciunt. Et reprehenderit consequatur vel voluptas. Consequuntur maxime placeat et repudiandae magnam porro. Natus quasi et illo distinctio consequatur commodi ut nemo. Consequatur doloremque expedita dolor corporis eveniet. Omnis aperiam quas quo nobis beatae cumque.

Quasi fugit sed quo eveniet. Explicabo quidem quia possimus odio alias nobis.

Aliquam consequatur non voluptas quis asperiores nesciunt doloribus optio. Recusandae nostrum repudiandae numquam culpa vel at. Velit fugit aspernatur autem et autem sequi magni. Laboriosam velit ducimus non quo dolor voluptatem pariatur.

Possimus commodi id harum voluptate qui explicabo voluptatem omnis. Quas vel laboriosam impedit provident voluptatibus rerum repellat. Adipisci et delectus pariatur pariatur dicta minima.

Career Advancement Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • JPMorgan 01 98.4%
  • Morgan Stanley 08 97.8%
  • Goldman Sachs 02 97.3%

Overall Employee Satisfaction

August 2026 Investment Banking

  • Moelis & Company No 99.5%
  • Evercore No 98.9%
  • Morgan Stanley 01 98.4%
  • Banco Santander 02 97.8%
  • BMO Capital Markets 12 97.3%

Professional Growth Opportunities

August 2026 Investment Banking

  • Evercore 01 99.5%
  • Moelis & Company 01 98.9%
  • Morgan Stanley 06 98.4%
  • Goldman Sachs 01 97.8%
  • JPMorgan 01 97.3%

Total Avg Compensation

August 2026 Investment Banking

  • Vice President (16) $429
  • Associates (48) $259
  • 3rd+ Year Analyst (8) $210
  • 2nd Year Analyst (25) $178
  • Intern/Summer Associate (14) $159
  • 1st Year Analyst (83) $151
  • Intern/Summer Analyst (75) $101
notes
16 IB Interviews Notes

“... there’s no excuse to not take advantage of the resources out there available to you. Best value for your $ are the...”

Leaderboard

1
redever's picture
redever
99.2
2
kanon's picture
kanon
99.0
3
BankonBanking's picture
BankonBanking
99.0
4
Secyh62's picture
Secyh62
99.0
5
dosk17's picture
dosk17
98.9
6
DrApeman's picture
DrApeman
98.9
7
GameTheory's picture
GameTheory
98.9
8
Betsy Massar's picture
Betsy Massar
98.9
9
CompBanker's picture
CompBanker
98.9
10
bolo up's picture
bolo up
98.8
success
From 10 rejections to 1 dream investment banking internship

“... I believe it was the single biggest reason why I ended up with an offer...”